Sentry Investment Management LLC Has $115,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sentry Investment Management LLC cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.0% in the fourth quarter, HoldingsChannel reports. The fund owned 1,469 shares of the company’s stock after selling 239 shares during the quarter. Sentry Investment Management LLC’s holdings in GE HealthCare Technologies were worth $115,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of GEHC. Allspring Global Investments Holdings LLC boosted its position in GE HealthCare Technologies by 2.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after acquiring an additional 562 shares during the period. Assenagon Asset Management S.A. boosted its position in GE HealthCare Technologies by 10.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock worth $1,289,000 after acquiring an additional 1,256 shares during the period. State of Alaska Department of Revenue boosted its position in GE HealthCare Technologies by 14.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 53,033 shares of the company’s stock worth $4,977,000 after acquiring an additional 6,870 shares during the period. Nisa Investment Advisors LLC boosted its position in GE HealthCare Technologies by 2.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company’s stock worth $7,165,000 after acquiring an additional 1,920 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its position in GE HealthCare Technologies by 111.1% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 5,792 shares of the company’s stock worth $544,000 after acquiring an additional 3,048 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $90.67 on Thursday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business’s 50 day moving average is $85.76 and its two-hundred day moving average is $86.05. The company has a market cap of $41.46 billion, a P/E ratio of 20.94, a P/E/G ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.